Welcome to our dedicated page for Intelithrive SEC filings (Ticker: ITHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Intelithrive's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Intelithrive's regulatory disclosures and financial reporting.
Intelithrive, Inc. reported the resignations of Chief Executive Officer Paul Ogorek and officer Sam Becherer, each effective June 15, 2026. Mr. Ogorek's resignation cites an ongoing dispute with the company's majority shareholder over transfers of 5,880,000 shares (approximately 57.42%) and 10,000,000 Series A preferred shares.
The filings state the contested transfers were made to Newton Companies under contractual arrangements Mr. Ogorek believes were not performed as agreed; the resignation letters are attached as exhibits. The report frames these events as governance and control disputes affecting the company's leadership.